Abstract
Introduction
Carallia brachiata Merr. belongs to the family Rhizophoraceae (Vietnamese name is “săng mã”).
1
The leaves and wood of this plant have been used for a long time in Vietnamese folk medicine to treat mouth ulcers, tongue sores, sore throats, and malaria. The previous publications have reported megastigmane, 1,2-dithiolane derivative, flavonoids, tannins, glyceroglycolipids, aromatic compounds, alkaloid, and lignans isolated from this plant.2-5 Some of these compounds showed antiinflammatory and antimicrobial activity.2-5 The present paper reports two new (
Results and Discussion
The dried leaves and branches of C. brachiata were extracted with methanol. The methanolic extract was suspended with water and then successively separated with n-hexane and ethyl acetate to give n-hexane soluble fraction, ethyl acetate soluble fraction, and water-soluble fraction. These fractions were then evaluated for their NO inhibitory activity to give an active fraction (ethyl acetate fraction). The ethyl acetate fraction was subjected to isolation and purification by chromatographic methods to obtain nine secondary metabolites (
The HR-ESI-MS of

Structures of

Key HMBC and COSY interactions of
1H and 13C NMR Data for
Measured in aMethanol-d4 and bDMSO-d6.
The HR-ESI-MS spectrum of

Key NOESY correlations of

Experimental CD of
Continuing the bio-guided fractionation, the isolates were further screened for their NO production effects in LPS-activated RAW264.7 cells. At a concentrated solution of 100 µM, except for compounds
NO Production Inhibitory Effects of the Isolates on the RAW264.7 Cell.
*Dexamethasone was used as a positive control.
Material and Methods
General
The equipment and experimental procedures are provided in supporting materials.
Plant Materials
Carallia brachiata Merr. (leaves and branches) was collected in Trieu Son, Thanh Hoa in March 2021 and identified by Dr Do Van Hai at the Institute of Ecology and Biological Resources, VAST. The specimen (VAST.04.02/22-23) was kept at the Institute of Marine Biochemistry, VAST.
Extraction and Purification
This section is provided in supporting materials.
Carabrachiatanin A (1 )
A yellow solid;
Carabrachiatanin B (2 )
A yellow amorphous solid;
Calculation Theoretical CD spectra
An enantiomer (2R,3S,9R)-
Conclusions
Two new phenylpropanoid-substituted catechins (
Supplemental Material
sj-docx-1-npx-10.1177_1934578X231219074 - Supplemental material for Carabrachiatanins A and B: Two New Phenylpropanoid-Substituted Catechins of Carallia brachiata Merr
Supplemental material, sj-docx-1-npx-10.1177_1934578X231219074 for Carabrachiatanins A and B: Two New Phenylpropanoid-Substituted Catechins of Carallia brachiata Merr by Trinh Thi Thanh Van, Nguyen Hoang Nam, Nguyen Thi Hue, Le Nguyen Thanh, Do Thi Trang, Bui Huu Tai, Nguyen Le Tuan, Nguyen Thi Viet Ai, Pham Van Cuong, Nguyen Quoc Vuong and Phan Van Kiem in Natural Product Communications
Footnotes
Acknowledgments
We would like to thank Physician Bui Thi Vui, at Trieu Thanh, Trieu Son, Thanh Hoa for providing the plant sample and Dr Do Van Hai for the plant identification.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We would like to thank Vietnam Academy of Science and Technology for financial support (VAST 04.02/22-23).
Ethical Approval
Our institution does not require ethical approval for reporting individual cases or case series.
Statement of Human and Animal Rights
This article does not contain any studies with human or animal subjects.
Statement of Informed Consent
There are no human subjects in this article and informed consent is not applicable.
Supplemental Material
Supplemental material for this article is available online.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
